Close Menu

Using single-cell RNA sequencing, a Yale University-led team has built an atlas of aberrant cellular populations in idiopathic pulmonary fibrosis (IPF), a fatal interstitial lung disease characterized by irreversible scarring of the distal lung. As they report in Science Advances, the investigators profiled 312,928 cells from 32 IPF patient lungs, the lungs of 28 smoker and nonsmoker controls, and 18 lungs from individuals with chronic obstructive pulmonary disease.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.